SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

74,248.45 -654.14
( -0.87%)

Global Indices

Nasdaq

52,089.49 -312.17
(-0.60%)

Dow Jones

7,612.71 -44.65
(-0.58%)

Hang Seng

65,056.24 -86.54
(-0.13%)

Nikkei 225

10,611.90 -58.16
(-0.55%)

Forex

USD-INR

95.06 0.32
(0.34%)

EUR-INR

110.60 0.49
(0.45%)

GBP-INR

128.80 0.53
(0.41%)

JPY-INR

0.62 0.00
(0.59%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Dr Reddys Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500124

INE089A01031

377.9540829

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

DRREDDY

143.5

95220.28

EPS(TTM)

Face Value()

Div & Yield %

7.95

0.7

Back

bajaj finserv ltd

Bajaj Finserv consolidated net profit rises 12.31% in the June 2026 quarter

Jul 31,2026

Net profit of Bajaj Finserv rose 12.31% to Rs 3132.35 crore in the quarter ended June 2026 as against Rs 2789.05 crore during the previous quarter ended June 2025. Sales rose 19.37% to Rs 41670.09 crore in the quarter ended June 2026 as against Rs 34907.91 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	41670.09	34907.91	19
OPM %	41.13	41.01	-
PBDT	9311.87	7520.97	24
PBT	8932.19	7203.64	24
NP	3132.35	2789.05	12

74,248.45 -654.14 ( -0.87%)

52,089.49 -312.17 (-0.60%)

7,612.71 -44.65 (-0.58%)

65,056.24 -86.54 (-0.13%)

10,611.90 -58.16 (-0.55%)

95.06 0.32 (0.34%)

110.60 0.49 (0.45%)

128.80 0.53 (0.41%)

0.62 0.00 (0.59%)